Brainify.AI (also known as Neuroscience Software) is an AI biomarker platform for the development of novel treatments for depression. It specializes in analyzing electroencephalogram data and predicting patients' treatment outcomes before the treatment begins. The company enables EEG biomarkers to diagnose depression, determine the stage and type of the disorder, and predict treatment.